β-globin Restored Autologous HSC in β-thalassemia Major Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04205435 |
Recruitment Status :
Terminated
(Sponsor decision)
First Posted : December 19, 2019
Last Update Posted : October 13, 2022
|
Sponsor:
Bioray Laboratories
Collaborator:
PLA 923 Hospital
Information provided by (Responsible Party):
Bioray Laboratories
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Terminated |
---|---|
Actual Primary Completion Date : | June 1, 2022 |
Actual Study Completion Date : | July 25, 2022 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):